Shunrou Fujiwara1, Yoshichika Yoshioka2, Tsuyoshi Matsuda3, Hideaki Nishimoto4, Toshiyuki Murakami4, Akira Ogawa4, Kuniaki Ogasawara4, Takaaki Beppu4,5. 1. Department of Neurosurgery, Iwate Medical University, 19-1 Uchimaru, Morioka, Iwate, 020-8505, Japan. shunfuji@iwate-med.ac.jp. 2. Laboratory of Biofunctional Imaging, WPI Immunology Frontier Research Center, Osaka University, Osaka, Japan. 3. MR Applications and Workflow Asia Pacific, GE Healthcare Japan, Tokyo, Japan. 4. Department of Neurosurgery, Iwate Medical University, 19-1 Uchimaru, Morioka, Iwate, 020-8505, Japan. 5. Department of Hyperbaric Medicine, Iwate Medical University, Iwate, Japan.
Abstract
INTRODUCTION: Brain temperature (BT) is associated with the balance between cerebral blood flow and metabolism according to the "heat-removal" theory. The present study investigated whether BT is abnormally altered in acute and subacute CO-poisoned patients by using (1)H-magnetic resonance spectroscopy (MRS). METHODS: Eight adult CO-poisoned patients underwent 3-T magnetic resonance imaging in the acute and subacute phases after CO exposure. MRS was performed on deep cerebral white matter in the centrum semiovale, and MRS-based BT was estimated by the chemical shift difference between water and the N-acetyl aspartate signal. We defined the mean BT + 1.96 standard deviations of the BT in 15 healthy controls as the cutoff value for abnormal BT increases (p < 0.05) in CO-poisoned patients. RESULTS: BT of CO-poisoned patients in both the acute and subacute phases was significantly higher than that of the healthy control group. However, BT in the subacute phase was significantly lower than in the acute phase. On the other hand, no significant difference in body temperature was observed between acute and subacute CO-poisoned patients. BT weakly correlated with body temperature, but this correlation was not statistically significant (rho = 0.304, p = 0.2909). CONCLUSIONS: The present results suggest that BT in CO-poisoned patients is abnormally high in the acute phase and remains abnormal in the subacute phase. BT alteration in these patients may be associated with brain perfusion and metabolism rather than other factors such as systemic inflammation and body temperature.
INTRODUCTION: Brain temperature (BT) is associated with the balance between cerebral blood flow and metabolism according to the "heat-removal" theory. The present study investigated whether BT is abnormally altered in acute and subacute CO-poisoned patients by using (1)H-magnetic resonance spectroscopy (MRS). METHODS: Eight adult CO-poisoned patients underwent 3-T magnetic resonance imaging in the acute and subacute phases after CO exposure. MRS was performed on deep cerebral white matter in the centrum semiovale, and MRS-based BT was estimated by the chemical shift difference between water and the N-acetyl aspartate signal. We defined the mean BT + 1.96 standard deviations of the BT in 15 healthy controls as the cutoff value for abnormal BT increases (p < 0.05) in CO-poisoned patients. RESULTS:BT of CO-poisoned patients in both the acute and subacute phases was significantly higher than that of the healthy control group. However, BT in the subacute phase was significantly lower than in the acute phase. On the other hand, no significant difference in body temperature was observed between acute and subacute CO-poisoned patients. BT weakly correlated with body temperature, but this correlation was not statistically significant (rho = 0.304, p = 0.2909). CONCLUSIONS: The present results suggest that BT in CO-poisoned patients is abnormally high in the acute phase and remains abnormal in the subacute phase. BT alteration in these patients may be associated with brain perfusion and metabolism rather than other factors such as systemic inflammation and body temperature.
Entities:
Keywords:
Brain metabolism; Brain temperature; CO poisoning; Delayed neuropsychiatric sequelae; Magnetic resonance spectroscopy
Authors: N Watanabe; S Nohara; H Matsuda; H Sumiya; K Noguchi; M Shimizu; S Tsuji; S Kinuya; N Shuke; K Yokoyama; H Seto Journal: Nucl Med Commun Date: 2002-04 Impact factor: 1.690
Authors: J De Reuck; D Decoo; I Lemahieu; K Strijckmans; P Boon; G Van Maele; W Buylaert; D Leys; H Petit Journal: J Neurol Date: 1993-07 Impact factor: 4.849
Authors: Stephen R Thom; Veena M Bhopale; Donald Fisher; Jie Zhang; Phyllis Gimotty Journal: Proc Natl Acad Sci U S A Date: 2004-09-01 Impact factor: 11.205
Authors: William N Whiteley; Ralph Thomas; Gordon Lowe; Ann Rumley; Bartosz Karaszewski; Paul Armitage; Ian Marshall; Katherine Lymer; Martin Dennis; Joanna Wardlaw Journal: Neurology Date: 2012-06-27 Impact factor: 9.910